Peripheral neuropathy and myopathy in long-term hemodialysis patients
スポンサーリンク
概要
- 論文の詳細を見る
Clinical, blood biochemical, electrophysiological and pathological studies were done for both uremic peripheral neuropathy and uremic myopathy in 25 long-term hemodialysis patients, and the results were compared with 30 patients on conservative therapy. The mean period of hemodialysis was three yearsand three months. Ccr in the conservative therapy group was 4.1±0.4 (mean±SE) m<I>l</I>/min. Of the 25 hemodialysis patients, neurogenic changes were recognized in all 25 (100%) and myogenic changes in six (24%). Of the30 patients on conservative therapy, neurogenic changes were seen in 19 (63%) and myogenic changes in 13 (43%). Four (13%) showed no abnormalities. Mixed changes were seen in both groups. Maximum motor nerve conduction velocity and maximum sensory nerve conduction velocity were more frequently slowed and showed significantly (p<0.001-p<0.02) lower values in the dialysis group compared with those on conservative therapy. Consequently, the two groups exhibited no significant differences in myopathy, whereas peripheral neuropathy was more frequent and more severe in the dialysis group. Accordingly, improvement in or disappearance of peripheral neuropathy cannot be expected with standard hemodialysis.
- 社団法人 日本透析医学会の論文
社団法人 日本透析医学会 | 論文
- 4.血液浄化療法の生体適合性と腎性貧血
- PD-HD併用療法においての腎機能保護の可能性 : 第51回日本透析医学会ワークショップより
- 腹部大動脈人工血管の仮性動脈瘤破裂,および右大腿回旋動脈の仮性動脈瘤破裂をきたした血液透析患者の1例
- 5.透析患者のインスリン抵抗性と腎性貧血
- 摘出腫瘤の病理組織標本所見より頸椎腫瘍状石灰沈着症 (cervical tumoral calcinosis) と診断し得た維持透析患者の1例